NASDAQ · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Cuprina Holdings (Cayman) Limited CUPR
4 fiscal years on record · SGD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
SGD 49,894
▲ 3.3% vs FY2024
EPS · FY25
—
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-1569.1%
Net margin · FY25
-9366.8%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
SGD 49,894.00
Revenue, FY2025 · full 4-year series below
Revenue
Net income
The company lost 9367 cents on every revenue dollar this year.
Per share
—
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-1569.1%
Return on equity, FY2025
ROE
Operating margin-9680.2%
Net margin-9366.8%
Return on assets-91.2%
Each SGD of equity lost 1569 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−4.1%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
SGD 8.5M
total assets, end of FY2025
Total assetsSGD 8.5M
EquitySGD 5.1M
CashSGD 3.1M
Gross debtSGD 164,929.00
Net debtSGD -3.0M
Current ratio2.35×
The company holds more cash than debt.
History
4 fiscal years
Every figure from documents filed with the SEC · SGD
Metric
2025
2024
2023
2022
Revenue SGD B
0.0
0.0
0.0
0.0
Operating income SGD B
−0.0
−0.0
−0.0
−0.0
EBITDA SGD B
−0.0
−0.0
−0.0
−0.0
Income tax SGD B
·
·
·
·
Net income SGD B
−0.0
−0.0
−0.0
−0.0
EPS, diluted SGD
·
·
·
·
Dividend / sh SGD
·
·
·
·
Payout %
·
·
·
·
ROE %
−1569.1
·
·
·
Shares out B
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
10 of 14
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 4 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed